Investor 272 Capital LP
13D/G Filings

This page shows a list of all the recent 13D/G filings made by 272 Capital LP . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2025-07-11 13D/A SQNS / Sequans Communications S.A. - Depositary Receipt (Common Stock) 45,013,764 40,251,840
2025-02-14 13G/A CDZI / Cadiz Inc. 3,522,582 1,050,000
2024-11-14 13G/A HBIO / Harvard Bioscience, Inc. 2,939,278 1,555,820
2024-11-14 13G CDZI / Cadiz Inc. 3,522,582
2024-02-14 13G/A AREN / The Arena Group Holdings, Inc. 1,654,698 0
2024-02-14 13G/A HBIO / Harvard Bioscience, Inc. 3,264,796 2,939,278
2023-10-27 13D/A SQNS / Sequans Communications S.A. - Depositary Receipt (Common Stock) 19,870,548 45,013,764
2023-02-16 13G/A AREN / The Arena Group Holdings, Inc. 1,654,698 1,654,698
2023-02-16 13G/A HBIO / Harvard Bioscience, Inc. 3,264,796 3,264,796
2023-02-16 13G/A INTT / inTEST Corporation 836,918 0
2023-02-15 13G HBIO / Harvard Bioscience, Inc. 3,264,796
2023-02-15 13G AREN / The Arena Group Holdings, Inc. 1,654,698
2022-12-05 13D/A SQNS / Sequans Communications S.A. - Depositary Receipt (Common Stock) 17,787,348 19,870,548
2022-10-18 13D/A CAMP / Camp4 Therapeutics Corporation 2,229,159 3,126,959
2022-09-06 13D/A SQNS / Sequans Communications S.A. - Depositary Receipt (Common Stock) 14,413,332 17,787,348
2022-07-22 13D CAMP / Camp4 Therapeutics Corporation 1,375,465 2,229,159
2022-06-22 13D/A CAMP / Camp4 Therapeutics Corporation 1,354,678 1,375,465
2022-05-26 13D CAMP / Camp4 Therapeutics Corporation 1,354,678
2022-03-24 13D SQNS / Sequans Communications S.A. - Depositary Receipt (Common Stock) 14,413,332
2021-01-20 13G INTT / inTEST Corporation 836,918